Hostname: page-component-5ffc9858b4-w82pp Total loading time: 0 Render date: 2025-03-25T06:20:28.065Z Has data issue: false hasContentIssue false
  • English
  • Français

In Reply to “Thyrotoxic Periodic Paralysis, β2-Adrenergic Bronchodilator, and Insulin—An Interesting Interplay”

Published online by Cambridge University Press:  04 March 2015

Chih-Jen Cheng  and
Shih-Hua Lin
Chih-Jen Cheng
Affiliation:
Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center Taipei, Taiwan
Shih-Hua Lin
Affiliation:
Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center Taipei, Taiwan

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters • Correspondance
Information
Canadian Journal of Emergency Medicine , Volume 16 , Issue 5 , September 2014 , pp. 344
Copyright
Copyright © Canadian Association of Emergency Physicians 2014

References

1. Yeh, FC, Chiang, WF, Wang, CC, Lin, SH. Thyrotoxic periodic paralysis triggered by b2-adrenergic bronchodilators. CJEM 2013;15:1–5.Google Scholar
2. Senthilkumaran, S, Nath Jena, N, Jayaraman, S, Thirumalaikolundusubramanian, P. Thyrotoxic periodic paralysis, β2-adrenergic bronchodilator, and insulin—an interesting interplay. CJEM 2014;16:343.Google Scholar
3. St-Pierre, DH, Benso, A, Gramaglia, E, et al. The metabolic response to the activation of the beta-adrenergic receptor by salbutamol is amplified by acylated ghrelin. J Endocrinol Invest 2010;33:363–7.Google Scholar
4. Chang, CC, Cheng, CJ, Sung, CC, et al. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol 2013;169:529–36, doi:10.1530/EJE-13-0381.Google Scholar
5. Jongjaroenprasert, W, Phusantisampan, T, Mahasirimongkol, S, et al. A genomewide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis. J Hum Genet 2012;57:301–4, doi:10.1038/jhg.2012.20.Google Scholar
6. Ryan, DP, da Silva, MR, Soong, TW, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemicperiodic paralysis. Cell 2010; 140:88–98, doi:10.1016/j.cell.2009.12.024.CrossRefGoogle ScholarPubMed